Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe two screenshots depict the same study page with minor UI/layout adjustments; core study content such as the title, objectives, eligibility, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedCore page now includes a government funding/operating-status notice and a new version v3.2.0, replacing the older v3.0.2.SummaryDifference2%

- Check51 days agoChange Detected- Updated version label from v3.0.1 to v3.0.2. - Removed the old revision tag (v3.0.1) and a Back to Top cue. - Overall impact appears to be a branding/version update with minimal to no change in core content or user-facing features.SummaryDifference0.1%

- Check59 days agoChange DetectedVersion bumped from v3.0.0 to v3.0.1 and a Back to Top control was added; this is a minor patch and UX enhancement with no substantive content changes.SummaryDifference0.1%

- Check87 days agoChange DetectedThe webpage has undergone significant changes, including the removal of numerous principal investigator contact details and the addition of new dates for updates. The revision number has also been updated.SummaryDifference19%

- Check94 days agoChange DetectedThe page has updated its contact information for two principal investigators, Clay M. Hoerig and Rebecca J. Deyell, and has revised the last update date and version number.SummaryDifference0.6%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.